About
At Allogeneic Solutions, we are dedicated to excellence in allograft distribution, placing the highest value on our relationships. Our unwavering commitment to safety, clinical efficacy, and quality has fostered partnerships with leading innovators, providing access to a diverse range of advanced biologics. We take pride in offering regenerative medicine solutions that set new industry standards.
Strategically located in Atlanta, Georgia and the greater Reno, Nevada area. Allogeneic Solutions is ideally positioned to support Medical Professionals nationwide with a comprehensive range of brand-name biologics for wound care, surgical indications, sports medicine, and amniotic membrane transplantation for eyecare.
Regenerative Medicine
Regenerative human cellular and tissue products, a category within human cellular and tissue-based products, refer to treatments that utilize living cells or tissues from humans to replace or repair damaged or diseased body parts. The FDA also refers to these products as human cellular and tissue-based products or (HCT/Ps).
The FDA has established comprehensive industry standards to monitor and regulate tissue transplant products, including stem cells, to ensure maximum patient safety. Cellular and tissue products that adhere to FDA-defined criteria are not classified as drugs but as HCT/P 361 products. While these products are FDA-regulated, they are not FDA-approved. When conducting HCT/P provider due diligence prioritize organizations that have not warranted written interaction with the FDA.
RingBack Request
ADJECTIVE: Denoting, relating to, or involving tissues or cells that are genetically dissimilar and hence immunologically incompatible, although from individuals of the same species.